Financing

Payments For Repurchase Of Initial Public Offering

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
Metric ID: financing_payments_for_repurchase_of_initial_public_offering

Historical Data

2 periods
 Q1 '25Q1 '26
Value$0.00$3.04M
Range$0.00 – $3.04M

Frequently Asked Questions

What is Kailera Therapeutics 's payments for repurchase of initial public offering?
Kailera Therapeutics (KLRA) reported payments for repurchase of initial public offering of $3.04M in Q1 2026.